Medacta Gains CE Mark for Shoulder Implants
The two components allow surgeons to widen clinical use of the system by addressing more patient morphologies and pathologies....
Jun 03, 2020,
Medacta Gains CE Mark for Shoulder Implants
Patient Confidence Improving but Situation Remains Fluid
Patient sentiment and confidence will play a key role in the COVID-19 orthopedic procedure recovery. What can we learn about...
Jun 02, 2020,
Meditech Spine Gains FDA Clearance for CURE OPEL-L (S)
The new lumbar plate option expands the previously-cleared CURE LP system and complements the Talos-A (HA) Interbody device....
Jun 02, 2020,
SI-BONE’s iFuse SI Fusion Implant Covered by Aetna
The positive coverage policy further validates acceptance of iFuse as a treatment option for patients with chronic sacroiliac joint dysfunction....
May 29, 2020,
Medacta Announces First Surgery with Mecta-C Stand Alone Device and New Registrations
Mecta-C Stand Alone has also obtained CE Mark approval in Australia, and will soon be launched there and select areas...
May 28, 2020,
Nexxt Spine Gains FDA Clearance for ALIF and Lateral Systems
ALIF launches August 2020 and Lateral in September 2020. An integrated plate system is slated for for each product in...
May 28, 2020,
Conformis Settles Patent Dispute with Zimmer Biomet
Conformis and Zimmer Biomet settled disputes related to patient-specific instrument patents for use with off-the-shelf knee, hip and shoulder implants....
May 28, 2020,
First Korean Patent Approval for Episurf Medical
The patent covers Episurf Medical’s 3D-based damage marking technology, central to the Episealer® implant system....
May 28, 2020,
Life Spine’s First Cases with DYNA-LINK Ti Stand-Alone ALIF Spacer
DYNA-LINK Ti features the company's proprietary OSSEO-LOC™ surface technology and large, open graft windows....
May 28, 2020,
Axis Spine Gains FDA Clearance for Axis-ALIF
Axis has developed a platform technology of build in situ modular cages as an alternative to conventional designs....
May 27, 2020,
Loading new posts...
No more posts
